CBSTP Alumni

Amy McCalla, D.V.M., Ph.D.

• PROGRAM GRADUATE 2019

PositionPosition:

• Research Biologist, National Institute of Environmental Health Sciences, Molecular Endocrinology Group, Research Triangle Park, NC

CollegeCollege:

North Carolina State University (D.V.M. and Ph.D.)

Dr. McCalla-Martin was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with North Carolina State University and the National Cancer Institute, July 2010 - 2019.

Dr. McCalla-Martin received her BS in Microbiology and Molecular Cell Sciences from The University of Memphis in 2001. Following this degree she was a member of Dr. Stephen Skapek’s lab at St. Jude Children’s Research Hospital until 2004. During this time she developed two Arf transgenic mouse models as well as an Arf null knock-out mouse model. She coauthored four publications with the Skapek lab and was the primary author on an additional publication. Research undertaken in this lab examined the role of p19Arf in vascular remodeling and development of the disease persistent hyperplastic primary vitreous.

In 2005, Dr. McCalla-Martin joined Dr. Jorge Piedrahita’s lab at North Carolina State University. She coauthored two publications with this lab on research involving porcine microarray systems and the correlation between intrauterine growth restriction and somatic cell nuclear transfer techniques in swine. In January of 2010, she was primary author on a publication through this lab which described the Gli2 transgenic pig.

Dr. McCalla-Martin began the DVM program at NCSU in the fall of 2006. During her DVM program she continued to work with the Skapek and Piedrahita labs and presented research from both labs at the annual ACVP conferences in 2007 and 2008.  She entered the NCI molecular pathology GPP in partnership with North Carolina State University and the National Cancer Institute in July 2010.  With her initial diagnostic pathology and pre-dissertation research training at the NCSU completed in 2012, she relocated to Bethesda, MD to begin her dissertation research at the National Cancer Institute, under the direction of Lee Helman, M.D. and Natasha Caplan, Ph.D.   Her research focused on identification of molecular targets in Ewing's sarcoma and development of a mouse model.

Kara Corps, M.S., D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2018

PositionPosition:

• Assistant professor at Ohio State University, Columbus, OH

CollegeCollege:

Michigan State University (D.V.M.), North Carolina State University (Ph.D.)

Dr. Corps was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with North Carolina State University and the National Institute of Neurological Disorders and Stroke, July 2010 - May 2018.

Dr. Corps received her B.S. from Michigan State University. After completing the didactic portion of veterinary school, Dr. Corps spent 2008 working towards a M.S. in Comparative Medicine and Integrative Biology under Jack Harkema, D.V.M., Ph.D.,Diplomate, ACVP at Michigan State University. She defended her MS thesis in December 2008. Dr. Corps received her D.V.M. from Michigan State University in May 2010. She entered the NCI Molecular Pathology GPP in partnership with North Carolina State University and the National Institute of Neurological Disorders and Stroke in July 2010.  She completed the initial diagnostic pathology and pre-dissertation research training at the NCSU in 2012, and received her Ph.D. in May of 2018. Her other research interests focus on comparative neuropathology. 

Helen Michael, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2018

PositionPosition:

• Director of Clincial Research, IDEXX Laboratories, Westbrook, Maine

CollegeCollege:

University of Minnesota (D.V.M.), University of Maryland (Ph.D.)

Dr. Michael was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with the University of Maryland and the National Cancer Institute, July 2012-October 2018.

Dr. Michael received her bachelor’s degree from Carleton College and her D.V.M. from the University of Minnesota in May of 2008.  Prior to joining the program she completed a residency in clinical pathology at the University of Minnesota.  Her research focuses on the role of childhood UV exposure in the development of melanocytic moles and the progression to melanoma. 

She recently won an NIH Graduate Student Research Award for her work and has given presentations at the Society for Melanoma Research annual meetings. 

Caroline Andrews, D.V.M, Ph.D.

• Diplomate, ACVP
• Program Graduate 2018

PositionPosition:

• Veterinary Pathologist, Charles River Laboratories, Frederick, MD

CollegeCollege:

University of Georgia (D.V.M.), Michigan State University (Ph.D.)

Dr. Andrews was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Michigan State University and the National Cancer Institute, July 2012 - September 2018.

Prior to joining the program Dr. Andrews received her D.V.M. in May of 2012 from the University of Georgia.  She completed the university portion of her research and pathology training in 2014 and began her dissertation research at NIH.  She completed her Ph.D. in September of 2018.  Her research interests include inflammation, immunopathology and regenerative medicine. 

Amy Flis, D.V.M., Ph.D.

• Diplomate, ACVP

PositionPosition:

• Investigative Pathologist, Sanofi

CollegeCollege:

North Carolina State University

Dr. Flis was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with North Carolina State University and the National Cancer Institute, 2017 –2023.

Prior to joining the program, Dr. Flis received her D.V.M in May of 2017 from Purdue University. She completed her diagnostic pathology training and didactic graduate coursework at North Carolina State University in Raleigh, NC. She then completed her dissertation research in the NCI Laboratory of Human Carcinogenesis under the mentorship of Bríd M. Ryan and Stefan Ambs. Her research focused on characterizing the antiproliferative signaling mechanisms of dopamine receptor D1 (DRD1) in lung cancer cells and investigating those mechanisms’ synergy with EGFR inhibition by small molecules. She received the Society of Toxicologic Pathology Resident and Student Poster Award in 2022 for her poster presentation titled “Investigating the Interactions of Dopamine Receptor D1 in Lung Cancer.”

Members of her graduate committee included: Bríd M. Ryan PhD MPH, Stefan Ambs PhD MPH, R. Mark Simpson DVM PhD DACVP, John Cullen DVM PhD DACVP, Michael W. Nolan DVM PhD DACVR, and committee head Philip L. Sannes PhD. 

Dr. Flis is now an investigative pathologist with Sanofi in Cambridge, MA.

Raisa Glabman, M.S., V.M.D.

• Diplomate, ACVP

PositionPosition:

• Comparative Pathologist, Fred Hutch Cancer Research Center

CollegeCollege:

Michigan State University

Dr. Glabman was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Michigan State University and the National Cancer Institute, 2017-2023. 

Prior to joining the program, Dr. Glabman received a master's degree in public health science from Tulane University in 2010 and her VMD in 2017 from the University of Pennsylvania. She completed her diagnostic pathology training and didactic graduate coursework at Michigan State University. She continued her research in the NCI's Molecular Imaging Branch under the mentorship of Dr. Peter Choyke and Dr. Noriko Sato. Her research centered on understanding the protumorigenic role of cancer-associated fibroblasts (CAFs) within the tumor microenvironment of mammary tumors using an MMTV-PyVT mouse model, and targeting CAFs using near-infrared photoimmunotherapy (NIR-PIT). 

Members of her graduate committee included: Gisela Hussey DVM, PhD, Dalen Agnew DVM PhD DACVP, Margaret Petroff PhD, Noriko Sato MD PhD, Peter Choyke MD and Mark Simpson DVM PhD DACVP. 

Sarah Cramer, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2017

PositionPosition:

• Senior Pathologist, ToxPath Specialists (a StageBio Company), Frederick, MD

CollegeCollege:

Cornell University (D.V.M.), University of Maryland (Ph.D.)

Dr. Cramer was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with University of Maryland and the National Cancer Institute, July 2011 – 2017. 

Prior to joining the program, Dr. Cramer received her B.A. in biology from St. Mary’s College of Maryland (2002) and her D.V.M. from Cornell University College of Veterinary Medicine (2008). She completed a residency in veterinary anatomic pathology at Oklahoma State University (2008 – 2011), and was board-certified by The American College of Veterinary Pathologists in 2011. In 2011, Dr. Cramer joined the CBSTP in partnership with the University of Maryland. She completed her dissertation research in the NCI Laboratory of Molecular Immunoregulation, headed by Scott Durum, Ph.D.

Dr. Cramer's research interests include pediatric oncology, IL-7R signaling pathways, leukemogenic genetic mutations, collaborative pathology, and digital image analysis of histology slides.

Tiffany (Reed) Lyle, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2016

PositionPosition:

• Assistant Professor, Purdue University, West Lafayette, IN

CollegeCollege:

University of Georgia (D.V.M.), Purdue University (Ph.D.)

Dr. Lyle was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with the Purdue University and the National Cancer Institute, July 2009 - 2016. 

Dr. Lyle received her B.S. from the University of Georgia and her D.V.M. from the University of Georgia (2008), and following graduation initiated anatomic pathology residency at Purdue University’s Animal Disease Diagnostic Laboratory. Following one year of residency training, Dr. Lyle enrolled in the Molecular Pathology GPP as an NCI Cancer Research Training Fellow. She completed her diagnostic pathology training and didactic coursework in 2011 and continued her research training at NCI. Her academic program advisors were Margaret A. Miller, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists, Jose Ramos-Vara, D.V.M., Ph.D., Diplomate, The European College of Veterinary Pathologists, and Stephen Lenz, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists, and Patricia Steeg, Ph.D., Head, Women's Malignancies Branch. Dr. Lyle’s research interests include breast cancer metastasis to the brain and brain microenvironment.

Dr. Lyle presented her work at the American College of Veterinary Pathologists’ November 2013 meeting in Montreal, Quebec, Canada.  Her presentation was titled, "Characterization Of The Brain Microenvironment Surrounding Permeable And Impermeable Lesions In A Mouse Model Of Brain Metastatic Inflammatory Breast Cancer".

Heather Tillman, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2015

PositionPosition:

• Investigative Pathologist, St. Jude Children's Research Hospital, Memphis,TN

CollegeCollege:

University of Georgia (D.V.M.), Michigan State University (Ph.D.)

Dr. Tillman was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with the Michigan State University and the National Cancer Institute, July 2008 - 2015. 

Dr. Tillman received her B.S.A. in Animal Science from the University of Georgia (2005), her D.V.M. also from the University of Georgia (2008), and her residency certificate in Veterinary Anatomic Pathology from Michigan State University (2011). She pursued her dissertation research and training in the molecular pathology of advanced prostate cancer. Her research focused on understanding the signal transduction relating to epithelial-mesenchymal plasticity and metastatic progression using the PbCre4;PTENfl/flTP53fl/fl mouse model. Members of her graduate committee were: Matti Kiupel, Dr. Med. Vet., Ph.D., Diplomate, The American College of Veterinary Pathologist (ACVP), Michigan State University; Kathleen Kelly, Ph.D., Laboratory of Genitourinary Cancer Pathogenesis, NCI; Vilma Yuzbasiyan-Gurkan, Ph.D., Michigan State University; Ingeborg Langohr, D.V.M. Ph.D., Diplomate, The American College of Veterinary Pathologists, Michigan State University; Joshua Webster, Ph.D., Diplomate, The American College of Veterinary Pathologists. 

Dr. Tillman received a First Place, Young Investigator Award, in Experimental Pathology, from the American College of Veterinary Pathologists, at their November 2013 meeting in Montreal, Quebec, Canada. "Deregulation of The Ras Signaling Axis Promotes Metastasis Via The Nfkb Pathway in The Pten-/-Tp53-/- Mouse Prostate Cancer Model". 

Joy Gary, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2015

PositionPosition:

• Senior Pathologist, StageBio, McKinney, TX
• Previously, Veterinary Medical Officer, CDC

CollegeCollege:

Colorado State University (D.V.M.), Michigan State University (Ph.D.)

Dr. Gary was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Michigan State University and the National Cancer Institute, 2009 - 2015. 

 Joy Gary received her B.S. in biology from Davidson College in North Carolina (2005) and her DVM from Colorado State University in 2009. She completed her didactic graduate studies and core diagnostic experience in veterinary anatomic pathology at Michigan State University. She continued her training in pathology and research in the Laboratory of Cancer Biology and Genetics for her dissertation work under the mentorship of Dr. Beverly Mock. She studied the role of an allelic variant of mTOR in BALB/c mice (R628C; C1977T) on the function of the protein as a kinase and in DNA damage repair.  She utilized a mouse that expresses the BALB/c allele of mTOR on a BL6;129 background to explore this allelic variant.  Members of her graduate committee included: Matti Kiupel, Dr. Med. Vet., Ph.D., Diplomate, The American College of Veterinary Pathologists (ACVP), Michigan State University; Beverly Mock, Ph.D, LCBG, NCI; Vilma Yuzbasiyan-Gurkan, Ph.D., Michigan State University; Jennifer Thomas, D.V.M. Ph.D., Michigan State University; and Joshua Webster, Ph.D., Diplomate, The American College of Veterinary Pathologists.

Dr. Gary presented her work, “Decreased mTOR Delays Thymic lymphoma Formation and Leads to Concurrent Down Regulation of CDK6 in Mice with Constitutively Activated Thymic AK”, at the annual meeting of the American Association of Cancer Research, Washington, D.C., April 2013. 

Leah Zadrozny, D.V.M., Ph.D.

• Program Graduate 2015

PositionPosition:

• Veterinary Pathologist, U.S. Food and Drug Administration (FDA), Silver Spring, MD

CollegeCollege:

North Carolina State University (D.V.M. and Ph.D.)

Dr. Zadrozny was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with North Carolina State University and the National Heart, Lung, and Blood Institute, 2008 - 2015. 

Dr. Zadrozny received her B.S. from the University of Vermont and her D.V.M. from North Carolina State University (2008) where she also completed a residency in veterinary anatomic pathology. Her dissertation research was accomplished in  the NHLBI Laboratory of Cardiac Energetics, where she studied the aortic macromolecular microstructure in healthy and diseased SR-BI KO/ApoER61h/h mice, a recently defined model of diet-inducedocclusive coronary atherosclerosis and coronary heart disease.  Her research interests are in modeling the functional pathophysiology of cardiovascular disease, with an emphasis on athersclerosis. Her Ph.D. dissertation studies were headed by principal investigator mentor Robert Balaban, Ph.D.  Members of her graduate guidance committee included Robert Balaban, Ph.D., John Cullen, V.M.D., Ph.D., Diplomate, The American College of Veterinary Pathologists, Mark Simpson, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists, and Edward Neufeld, Ph.D.

Tyler Peat, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2020

PositionPosition:

• National Cancer Institute

CollegeCollege:

Purdue University (D.V.M.), Purdue University (Ph.D.)

Dr. Peat was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Purdue University and the National Cancer Institute, July 2015 - 2020.

Prior to joining the program, Dr. Peat received his D.V.M in May of 2014 from the Purdue University. He recently completed his diagnostic pathology training and the university portion of his research at Purdue University in West Lafayette, Indiana and was in the Mock Laboratory at the NCI. His research interests include discovering novel drug combinations to treat multiple myeloma in humans, understanding mechanisms of drug synergy, and developing new animal models to test drug sensitivity. 

Dr. Peat is the recipient of the 2018 Dennis Sikes Award and the 2019 Center for Cancer Research Fellows and Young Investigators Travel Award for an Outstanding Oral Presentation.

Dr. Peat is now a anatomic pathologist for LabCorp in Greenfield, Indiana.

Laura Baseler, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2015

PositionPosition:

• Veterinary Pathologist, NAMSA (North American Science Associates), Northwood, OH

CollegeCollege:

Iowa State University (D.V.M.), Purdue University (Ph.D.)

Dr. Baseler was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Purdue University and the National Institute of Allergy and Infectious Diseases, July 2010 - 2015. 

Dr. Baseler received her B.S. and M.S. from Iowa State University. She also completed her D.V.M. degree at Iowa State University (2010). She began her graduate fellowship and pathology training in July of 2010 at Purdue University. After completion of the initial diagnostic pathology and pre-dissertation research training at the university, she relocated to Hamilton, MT for her dissertation research on emerging viral infections including Nipah virus and the Middle East respiratory syndrome (MERS) coronavirus, with Heinz Feldmann, M.D., Ph.D., at the National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories.  She received a travel award to present her work at the 32nd annual meeting of the American Society for Virology, State College, PA, July 20-24, 2013.“Histological Comparison Of Respiratory Tract Lesions In Hamsters Intranasally Inoculated With Nipah Virus Isolated From Malaysia Or Bangladesh.”

Upon recieving her Ph.D. in 2015, her career took her to the University of Texas MD Anderson Cancer Center as an asssistant professor.  In July of 2017, she moved to British Columbia, Canada to work at the University of British Columbia and the Animal Health Centre as a veterinary pathologist specializing in fish pathology, while still maintaining her position at the University of Texas MD Anderson Cancer Center.

Philip Martin, M.S., D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2014

PositionPosition:

• Investigative Pathologist, MedImmune/AstraZeneca , Gaithersburg, MD

ProfilesProfiles:

CollegeCollege:

Kansas State University (D.V.M.), University of Maryland (Ph.D.)

Dr. Martin was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with University of Maryland and the National Cancer Institute, 2005 – 2014. 

Dr. Martin received his B.S. from Northwestern University, his M.S. from Ohio University and his D.V.M. from Kansas State University in 2003. After completing the D.V.M. Dr. Martin went to the University of California, Davis for residency training in anatomic pathology in the Department of Veterinary Pathology. As an anatomic pathology resident Dr. Martin pursued specialty track training in the pathology of laboratory animals and undertook training in the UC Davis Comparative Pathology Laboratory and the Pathology Department of the California Regional Primate Center. In 2005 Dr. Martin began training in comparative pathology through the Graduate Partnership Program at the National Cancer Institute, Bethesda MD. The first year of the GPP program was spent completing graduate course work at the University of Maryland and in additional anatomic pathology training while working in the Comparative Molecular Pathology Unit with Dr. Mark Simpson. Dr. Martin accomplished board certification in Anatomic Pathology by The American College of Veterinary Pathologists in 2006. Dr. Martin is carried out his dissertation research in the NCI Laboratory of Genitourinary Cancer Pathogenesis, headed by Kathy Kelly, PhD. His Ph.D. dissertation research involved developing an in-vivo bioluminescent transgenic mouse model of prostate cancer metastasis for the purpose of investigating the molecular signaling mechanisms responsible for driving prostate cancer metastasis. Members of his graduate guidance committee included Siba Samal, B.V.Sc., Ph.D., Diplomate, The American College of Veterinary Microbiologists (chair), Xiaoping Zhu, D.V.M., Ph.D., Robert Dooling, Ph.D., Kathy Kelly, Ph.D., and Mark Simpson, D.V.M., Ph.D, Diplomate, The American College of Veterinary Pathologists. Upon receiving his Ph.D., Dr. Martin worked as a veterinary pathologist for the NCI Frederick’s Center for Advanced Preclinical Research.  He currently is employed by MedImmune/AstraZeneca.

Ian Moore, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2014

PositionPosition:

• Investigative Veterinary Pathologist/Associate Director, Division of Pathology, Emory National Primate Research Center (ENPRC)
• Associate Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine

CollegeCollege:

Tuskegee University (D.V.M.), Michigan State University (Ph.D.)

Dr. Moore was a scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Michigan State University and the National Institute of Allergy and Infectious Diseases, 2007-2014. 

Dr. Moore received his B.S. from Tuskegee University and his DVM from Tuskegee University School of Veterinary Medicine in 2006, and following graduation, entered a residency in anatomic pathology the Diagnostic Center for Population and Animal Health, Michigan State University. Following completion of initial diagnostic pathology training, Dr. Moore carried out his Ph.D. diossertation work in the NIAID’s Laboratory of Infectious Disease (LID) where, under the guidance of Dr. Kanta Subbarao, he studied the pathologic and immunologic responses of the ferret to wild-type Influenza virus infection. Dr. Moore’s PhD committee was chaired by Kurt Williams DVM, Ph.D., Diplomate, The American College of Veterinary Pathologists.

Dr. Moore presented his work, “The Association of Age and Clinical Disease in Ferrets Infected with Pandemic H1N1 Influenza Virus”, at the 32nd annual meeting of the American Society for Virology, State College, PA, July 20-24, 2013. He also presented at the American College of Veterinary Pathologists’ November 2013 meeting in Montreal, Quebec, Canada. His talk was titled, “Avian Influenza Virus And Central Nervous System (CNS) Infection In Ferrets: A Proposed Novel Route For CNS Invasion”.

His research interests include mechanisms of infectious disease in animal models.  He is currenlty employed by the National Institute of Allergy and Infectious Diseases as a veterinary pathologist, in Rockville, MD.

A. Sally Davis, D.V.M., Ph.D.

• Diplomate, ACVP and ACVM
• Program Graduate 2014

PositionPosition:

• Founder and Chief Scientific Officer at Marinas Bio, Inc.

ProfilesProfiles:

• http://linkedin.com/in/asallydavis

CollegeCollege:

North Carolina State University (D.V.M. and Ph.D.)

Dr. Davis was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with North Carolina State University and the National Institute of Allergy and Infectious Diseases, 2007-2014. 

She conducted her Ph.D. dissertation research in the laboratory of Dr. Jeffery K. Taubenberger, M.D.,Ph.D., Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH. Dr. Davis received her D.V.M. and Residency Certificate in Veterinary Anatomic Pathology in 2007 and 2009 respectively from North Carolina State University College of Veterinary Medicine. She also has a BA in Computer Science modified with education and a graduate certificate in secondary school science education from Dartmouth College. 

Currently, Dr. Davis leads scienfic operations at a startup in the cellular agriculture space. Specifically, she is working on making seafood delicacies outside of animals using in vitro techniques. Laboratory operations are based in Sacramento, CA. Dr. Davis is active in multiple scientific professional societies including senior leadership roles in the Histochemical Society and also serves on the editorial boards of the Journal of Histochemistry and Cytochemistry as well as the Veterinary Pathology. 

Prior, as an Assistant Professor for Experimental Veterinary Pathology at Kansas State University and Extraordinary Faculty at the University of Pretoria, Dr. Davis focused on the comparative pathogenesis as well as development of detection and mitigation techniques for several transboundary animal diseases of relevance to production animal agriculture including zoonotic emerging viruses such as Rift Valley fever virus, African swine fever virus as well as SARS-CoV-2.

At the NIAID her research focused on the comparative pathogenesis and response of a diversity of mammalian species to a variety of influenza A viruses, including reconstructed 1918 and 2009 H1N1 pandemic strains. Additionally, she studied the interspecies variability in host response to influenza A virus via in vivo experimentation, digital and light histopathology, immunohistochemistry and immunofluorescence. While at NIAID, she focused on methods development in the following areas:  diminishing autofluorescence in formalin-fixed, paraffin-embedded tissue, multi-label antibody and lectin based immunofluorescence, and validation of the in vitro cell models against human/animal tissues of origin.  This work led to additional collaborations in other areas of respiratory pathology.  Her graduate committee members included: Jeffery Taubenberger, M.D., Ph.D. (co-chair), J. Mac Law, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists (co-chair), James Shelhamer, M.D., Deputy Chief, Critical Care Medicine Department, Clinical Center, NIH and Fred Fuller, Ph.D., North Carolina State University, College of Veterinary Medicine.

Jessica Beck, D.V.M., Ph.D.

• Diplomate, ACVP
• PROGRAM GRADUATE 2020

PositionPosition:

• Staff Scientist, Molecular Imaging Branch, National Cancer Institute

CollegeCollege:

University of Georgia (D.V.M), Purdue University (Ph.D.)

Dr. Beck is a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Purdue University and the National Cancer Institute, July 2013 - December 2020.

Prior to joining the program, Dr. Beck received her D.V.M in May of 2013 from the University of Georgia. She competed her initial diagnostic pathology training and pre-dissertation research at Purdue University in West Lafayette, Indiana in 2015. At NCI, she is investigating the roles of cellular senescence in cancer and aging with particular focus on the use of senescence-inducing therapies in the treatment of glioblastoma multiforme and on mechanisms of radiation-induced brain injury in cancer survivors.

Tanasa S. Osborne, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2011

PositionPosition:

• Project Pathologist, Novartis Institutes for Biomedical Research, East Hanover, NJ

ProfilesProfiles:

CollegeCollege:

Tuskegee University (D.V.M.), University of Illinois (Ph.D.)

Dr. Osborne was a graduate scholar in the NCI molecular pathology GPP in partnership with the University of Illinois, Urbana-Champaign and the National Cancer Institute, from 2006 to 2010. 

Dr. Tanasa Osborne received her Doctorate of Veterinary Medicine (DVM) from Tuskegee University College of Veterinary Medicine in 2002. That same year, Dr. Osborne entered a combined residency/PhD training program in anatomic pathology with an emphasis on toxicologic pathology in the Department of Pathobiology at the University of Illinois at Urbana-Champaign. Upon completion of her residency in 2006 Dr. Osborne began graduate training in comparative pathology through the GPP at the NCI, Bethesda, MD. Her PhD dissertation research in metastasis biology was carried out in the Tumor and Metastasis Biology Section, headed by Chand Khanna, DVM, PhD in the Pediatric Oncology Branch. Her model system included using a transplantable syngeneic mouse model characterized by orthotopic growth of osteosarcoma in BALB/c mice at appendicular sites with spontaneous metastasis to the lung. She used this model to study the role of eukaryotic initiation factor 4E (eIF4E) in the various steps of the metastatic cascade in osteosarcoma. The title of her dissertation was “The role of eukaryotic initiation factor 4E (eIF4E) in osteosarcoma metastasis”. Members of her graduate guidance committee included: Wanda Haschek-Hock, BVSc, PhD, Diplomate, American College of Veterinary Pathologists and American Board of Toxicologists (Chair), Chand Khanna, DVM, PhD, Diplomate, American College of Veterinary Internal Medicine, Matthew A. Wallig, DVM, PhD, Diplomate, American College of Veterinary Pathologists, Lois L. Hoyer, PhD, and Timothy M. Fan, DVM, PhD, Diplomate, American College of Veterinary Internal Medicine.  Dr. Osborne joined the National Toxicology Program (NTP) Pathology Group at the National Institutes of Health Sciences (NIEHS) in 2012 as a Toxicologic Pathology Research Fellow. She participated in the design, evaluation, and interpretation of toxicity and carcinogenicity studies conducted at NTP contracted laboratories.  She gained invaluable experience in rodent toxicology studies and was able to contribute to the establishment of standards, nomenclature, and diagnostic criteria for rodent pathology.  Her fellowship allowed continued education toward enhancing molecular pathology techniques and specialized training in hepatobiliary toxicology.  She is now employed as a Project Pathologist at Novartis Institutes for Biomedical Research.   

Kevin Woolard, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2010

PositionPosition:

• Associate Professor of Pathology, Microbiology & Immunoglogy, University of California, Davis

ProfilesProfiles:

• http://www.vetmed.ucdavis.edu/faculty/results.cfm?fid=21117

CollegeCollege:

North Carolina State University (D.V.M. and Ph.D.)

Dr. Woolard was a graduate scholar in the NCI Molecular Pathology GPP in partnership with the North Carolina State University and the National Cancer Institute, from 2003 - 2010. 

Dr. Woolard graduated from veterinary school at North Carolina State in 2003.  Following graduation, Dr. Woolard remained at the College of Veterinary Medicine, entered the molecular pathology GPP as a Cancer Research Training Fellow and undertook graduate course work and training in anatomic pathology. During his diagnostic pathology training he formed an interest in neuro-pathology and in neural stem cell biology. Following these interests, he completed his Ph.D. dissertation research in the comparative genomics driving canine and human gliomagenesis, focusing on the establishment of the dog as a spontaneous model for human gliomagenesis, in the Neuro-Oncology Branch headed by Howard Fine, M.D. in Bethesda, MD.  Dr. Woolard’s graduate committee was headed by Howard A. Fine, M.D., head of the Neuro-Oncology Branch.  Other members of his graduate committee included: John Cullen, V.M.D., Ph.D., Diplomate, The American College of Veterinary Pathologists; Matthew Breen, Ph.D., Diplomate, The American College of Veterinary Pathologists; Dave Malarkey, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists; and Mark Simpson D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists.  After receiving his Ph.D. he continued his research in the Fine laboratory comparing canine and human glioma stem cells to physiologic embryonic and adult canine neural stem cells, to elicit signaling pathways involved in self-renewal commonly expressed in both populations. He believes the dog represents a unique opportunity for meaningful comparative research of this spontaneous, heterogeneous tumor in humans through its remarkable genetic and physiologic similarity to human disease. Through comparative Genomic analysis and investigation into self-renewal signaling pathways shared between human and canine glioma stem cells, and ultimately canine embryonic stem cells, he hopes not only to better understand the process of glioma development and progression, but also to identify future molecular targets for therapeutic intervention.  Dr. Woolard is currently an assistant professor of Pathology, Microbiology & Immunology at the University of California, Davis School of Veterinary Medicine. 

Heather Shive, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2010

PositionPosition:

• Assistant Professor, Ohio State University, Columbus, Ohio

ProfilesProfiles:

CollegeCollege:

North Carolina State University (D.V.M.), University of Maryland (Ph.D.)

Shive was a graduate scholar in the NCI molecular pathology GPP in partnership with the University of Maryland and the National Cancer Institute, from 2006 to 2010. 

Dr. Shive received her B.S. from the University of Arizona and her D.V.M from North Carolina State University, College of Veterinary Medicine in 2004. Following graduation, she joined the residency program in anatomic pathology in the Department of Pathobiology at Texas A&M University, College of Veterinary Medicine, wehre she trained for two years. She was accepted as a graduate fellow in molecular pathology through the Graduate Partnership Program (GPP) at the National Cancer Institute in 2006. While pursuing graduate training at the NCI, she achieved board certification in Anatomic Pathology by the American College of Veterinary Pathologists in 2007. Dr. Shive completed her dissertation research in the research laboratory of Dennis Hickstein, M.D., in the Experimental Transplantation and Immunology Branch at the NCI. The dissertation project was focused on investigating germline mutations in the breast cancer-2 gene (brca2) in the zebrafish (Danio rerio). These studies revealed a critical role for brca2 in ovarian development, and provide new insights into brca2 mutation and cancer susceptibility. Members of her graduate guidance committee included: Siba Samal, BVSc, Ph.D., Diplomate, The American College of Veterinary Microbiologists (chair); Dennis Hickstein, M.D.; Paul Liu, M.D., Ph.D. (NHGRI); Mark Simpson, D.V.M, Ph.D., Diplomate, The American College of Veterinary Pathologists; Liangli Yu, Ph.D. and Xiaoping Zhu, D.V.M, Ph.D. After receiving her Ph.D. in 2010, Dr. Shive accepted a Staff Scientist position in the NCI, CCR, Transplantation and Immunology Branch, where she continued her cancer research using the zebrafish model.  She served as an assistant professor at North Carolina State University, Raleigh, NC for several years before moving to Ohio State University, Columbus, Ohio. 

Schantel (Hayes) Bouknight, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2010

PositionPosition:

• Veterinary Pathologist, Charles River Laboratories, Raleigh-Durham, NC

ProfilesProfiles:

CollegeCollege:

Tuskegee University (D.V.M.), Michigan State University (Ph.D.)

Dr. (Hayes) Bouknight was a graduate Scholar in the NCI Molecular Pathology Graduate Partnership Program in partnership with Michigan State University and the National Institute of Diabetes and Digestive and Kidney Diseases, from 2005 – 2010. 

Dr. (Hayes) Bouknight received her B.S. from Fort Valley State University and her D.V.M. from Tuskegee University in 2004. After graduation, Dr. Hayes (Bouknight) pursued a residency in anatomic pathology in the Department of Pathobiology and Diagnostic Investigation at Michigan State University. In 2005, she was accepted into the NCI Molecular Pathology Graduate Partnership Program to continue graduate course work and training as a diagnostic pathologist at MSU. Following completion of her diagnostic training and course work, Dr. Hayes (Bouknight) accomplished board certification in anatomic pathology by The American College of Veterinary Pathologists in 2007. She then relocated to the NIH, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD to begin her dissertation research. Her research focused on the transcriptional regulation of adipocyte differentiation in a laboratory headed by Elisabetta Muller, Ph.D., within the NIDDK Genetics of Development and Disease Branch. Members of her graduate guidance committee included: Matti Kiupel D.V.M, Ph.D., Diplomate, The American College of Veterinary Pathologists (chair), Elisabetta Mueller, Ph.D., James Wagner,M.B.A., Ph.D., and Mark Simpson, D.V.M, Ph.D., Diplomate, The American College of Veterinary Pathologists. After receiving her Ph.D., Dr. (Hayes) Bouknight was employed by Lexicon Pharmaceuticals as a veterinary pathologist.  She now resides in Raleigh-Durham, NC where she serves as a veterinary pathologist for Charles River Laboratories.  

Yava Jones-Hall, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2010

PositionPosition:

• Associate Professor, Texas A&M University

ProfilesProfiles:

• http://www.purdue.edu/vet/directory/person.php?id=73

CollegeCollege:

Tuskegee University (D.V.M.), Michigan State University (Ph.D.)

Dr. Jones-Hall was a graduate scholar in the NCI Molecular Pathology GPP in partnership with Michigan State University and the National Cancer Institute, from 2004-2006 and 2007-2010. 

Dr. Jones-Hall obtained a bachelors of arts from Talladega College in 1999 and her doctorate of veterinary medicine from Tuskegee University in 2003. She pursued an anatomic pathology residency at Michigan State University. In 2004, she was accepted into the NCI Molecular Pathology Graduate Partnership Program to continue her graduate course work and training as a diagnostic pathologist at MSU. Captain Jones interrupted her Cancer Research Training Award training at MSU from 2006-2007 to deploy to Afghanistan in support of Operation Enduring Freedom with the United States Army Veterinary Corps. Following active duty, she returned to the program to pursue her Ph.D. dissertation research in the Cancer and Inflammation Program, Center for Cancer Research, at the National Cancer Institute located in Frederick, MD. Dr. Jones-Hall’s research topic involved studying the role of Tumor Necrosis Factor-α in the development and propagation of chemically induced colitis and colon cancer using mouse models. Her NIH principal investigator (PI) mentor was Giorgio Trinchieri, M.D. Her graduate committee members included: Dr. Trinchieri, Matti Kiupel, Dr. Med. Vet, Ph.D., Diplomate, The American College of Veterinary Pathologists, Vilma Yuzbasiyan-Gurkan, Ph.D., Alison Bauer, Ph.D., and Mark Simpson, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists. Dr. Jones-Hall received an appointment as an assistant professor at Purdue University.  In 2017, Dr. Jones-Hall became a tenured Associate Professor at Purdue University. She is now an Associate Professor in the Veterinary Pathobiology Department at Texas A&M University, College Station, TX where she serves as the director of the histology and histopathology core laboratory in the college of veterinary medicine and biomedical sciences.

David Caudell, D.V.M., Ph.D.

• Program Graduate 2008

PositionPosition:

• Associate Professor, Director of the Center for Comparative Medicine Research, Wake Forest School of Medicine, Winston Salem, NC

ProfilesProfiles:

CollegeCollege:

Virginia Tech (D.V.M.), University of Maryland (Ph.D.)

Dr. Caudell was a graduate fellow in the NCI molecular pathology GPP in partnership with University of Maryland from 2003-2008.  He completed his dissertation research in the Genetics Branch, under the mentorship of Peter Aplan, M.D. 

Dr. Caudell received his D.V.M. degree from Virginia Tech in 2000, followed by a residency in Anatomic Pathology in the Department of Pathobiology at Oklahoma State University, completed in 2003. Following his residency, Dr. Caudell pursued graduate training in comparative molecular pathology through the Graduate Partnership Program at the National Cancer Institute, Bethesda, MD. He completed his dissertation research in mouse models of human leukemia in the Genetics Branch, Leukemogenesis Section headed by Peter D. Aplan, M.D. Dr. Caudell defended his dissertation research and was awarded his Ph.D. degree from the University of Maryland in June 2008. The title of his Ph.D. dissertation is "Development of a mouse model for the t(10;11)(p13;q14) chromosomal translocation associated with acute leukemia in humans". Members of his graduate committee included: Siba K. Samal, B.V.Sc. Ph.D., Diplomate, The American College of Veterinary Microbiologists (Chair); Peter D. Aplan, M.D. (Co-Chair); Nathanial Tablante, D.V.M.,M.S., Diplomate, The American College of Poultry Veterinarians; R. Mark Simpson, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists; Iqbal Hamza, Ph.D. and Nickolas Zimmerman, Ph.D. After receiving his Ph.D., Dr. Caudell continued his research as a tenure track Assistant Professor in Pathology, in the Department of Pathobiology and Biomedical Sciences at Virginia Tech, Blacksburg, VA.  He remained in Blacksburg from 2009-2013.  In January, 2013, he continued to pursue his career as an assistant professor at Wake Forest School of Medicine, Winston Salem, North Carolina. After two years of helping to build reserach programs and resources there, he has been named the new Associate Director of the Center for Comparative Medicine Research.  

Mark J. Hoenerhoff, D.V.M., Ph.D.

• Diplomate, ACVP
• Program Graduate 2008

PositionPosition:

• Associate Professor, University of Michigan, Ann Arbor, MI

ProfilesProfiles:

CollegeCollege:

Michigan State University (D.V.M. and Ph.D.)

Hoenerhoff was a graduate fellow in the NCI molecular pathology GPP in partnership with Michigan State University from 2004-2008. 

Dr. Hoenerhoff received his DVM from Michigan State University College of Veterinary Medicine in 1998, followed by three years working as a clinician in a small animal and emergency practice. In 2001, Dr. Hoenerhoff returned to Michigan State University to pursue a residency in anatomic veterinary pathology in the Department of Pathobiology and Diagnostic Investigation. Following completion of his residency, Dr. Hoenerhoff received board certification in by The American College of Veterinary Pathologists in 2004, while pursuing graduate training in comparative pathology through the Graduate Partnership Program at the National Cancer Institute at the National Institutes of Health in Bethesda, MD. His dissertation research focused on breast cancer biology, breast cancer stem cells, and genetically engineered mouse (GEM) models of breast cancer in the Transgenic Oncogenesis Laboratory, led by Jeffrey Green, M.D., in the Laboratory of Cancer Biology and Genetics. Dr. Hoenerhoff defended his dissertation research and received his PhD degree from Michigan State University in May of 2008. The title of his Ph.D. dissertation is “BMI1 collaborates with HRAS to promote mammary tumorigenesis and metastasis”. Members of his graduate guidance committee included: Thomas Mullaney, D.V.M. Ph.D., The American College of Veterinary Pathologists, (Chair); Kurt Williams, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists; P.S. MohanKumar, B.V.Sc., Ph.D; Michael Scott, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists; Vilma Yuzbasiyan-Gurkan, Ph.D.; Jeff Green, M.D. and Mark Simpson, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists.  Following completion of his Ph.D., Dr. Hoenerhoff joined the Cellular and Molecular Pathology Branch at the National Institute of Environmental Health Sciences in the Research Triangle Park, NC, as Head of Investigative Pathology (2008-2013). His research focused on genetic and epigenetic mechanisms of chemically induced carcinogenesis and toxicity in National Toxicology Program (NTP) studies.  He has now returned to Michigan, his home state, where he accepted a position at the University of Michigan, Ann Arbor, MI as an associate professor.